Design and characterization of modified release Isoniazid and Salbutamol sulphate Inlay tablet

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 3, Issue 4, 2011, Pages 153-159

  Sarat Chandra Prasad, M ^a   Nagendra Babu, B ^a   Ajay, M ^a   Brito Raj, S ^a   Audinarayana, N ^a   Bhaskar Reddy, K ^a  

^a Sri Venkateswara College of Pharmacy   (India)

Author keywords

Hydroxy propyl methyl cellulose; Inlay tablet; Isoniazid; Salbutamol sulphate

Indexed keywords

EXCIPIENT; HYDROXYPROPYLMETHYLCELLULOSE; ISONIAZID; POLYMER; SALBUTAMOL SULFATE;

ARTICLE; ASTHMA; DRUG DESIGN; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG FORMULATION; DRUG GRANULATION; DRUG RELEASE; EXCIPIENT COMPATIBILITY; INFRARED SPECTROSCOPY; TUBERCULOSIS;

EID: 80054847342     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Liberman and Lachman, Tablet dosage forms, 2 Ed; (1), 72-104, 274, 275; (2) 34-98; (3)101-154.
2. Manoranjan Sahu, S.C. Dinda Formulation and development of modified release Inlayered tablet, Journal of Pharmacy Research 2010, 3(4), 794-798 Ed; (1), 72-104, 274, 275; (2) 34-98; (3)101-154.
3. th (Ed), 2008, 698-700.
4. th edition. 2005.
5. WHO, The International Pharmacopoeia. General Methods of Analysis, Quality Specifications for Pharmaceutical Substances, Excipients and Dosage Forms. 2004, 3 edition.
6. rd Edition. 2003. http://whqlibdoc. who.int/hq/2003/WHO_CDS_TB_2003.313_eng. pdf.
7. Indian pharmacopoeia, The Controller of Publications, New Delhi, Vol.1 1996; 408.
8. Zhao J, Takamura M, Yamaoka A, Odajima Y, Iikura Y. Altered eosinophil levels as a result of viral infection in asthma exacerbation in childhood. J Pediatr Allergy Immunol. 2002, 13(1):47-50.
9. Bradley JU, Lawrence ML. Drugs used in treatment of asthma. In: Hardman JG, Lee E., editors. Goodman and Gillman's: The pharmacological basis of therapeutics, 10 th ed. New York; the Mc Graw-Hill Companies: 2001. 735.
10. Peter JB, Robert AM, George RB, Principles of pharmacology: Basic concepts and clinical applications. New York; Thomson Publishing Company: 1995.589.
11. Md. Qamrul Ahsan, Md. Mofizur Rahman, Mithilesh Kumar Jha, Ishtiaq Ahmed, Md. Mizanur Rahman Moghal and Md. Habibur Rahman "Development and In-Vitro Evaluation of Sustained Release Matrix Tablets of Salbutamol Sulphate Using Methocel K100M Cr polymer", IJPSR, (2011); Vol. 2 Issue 3, 567-576.
12. Arvind K. Singh, Ramesh K. Singh "Development And Evaluation of Fast Disintegrating Tablets Of Salbutamol Sulphate by Superdisintegrating Agents", IJPSR (2010), Vol. 1, Issue 7, 47-53.
13. Suresh S, Mohammad Zakir Hussain, Saravanan C, Venkatesh S, Narayana Swamy V. B "Formulation and evaluation of sustained release matrix tablets of Isoniazid", Der Pharmacia Lettre, 2011, 3(1): 237-246.
14. nd Edition, Churchill Livingstone. 2002; 200-206.
15. Krishanaiah YS, Lath K, Nageshwara L, Karthikeyan RS, Bhaskar Pand Satyanarayana V. "Development of colon target oral guar gum matrix tablet of Albendazolefor the treatment of Helminthiasis". Indian J. Pharm. Sci. 2003; 65 (4): 378-385.
16. The United State of Pharmacopoeia 24/ Nf19 Asian Edition, The official compendia of standard United States pharmacopoeial convection Inc. Rockville. 1995; 1015, 1016, 1791.
17. Chaudhari PD. "Formulation and Evaluation of fast dissolving tablet of famotidine" Indian Drug. 2005; 42(10): 641-649.
18. th Ed. 1303-1304, 2588-2589, A133.
19. Sharad N. Shinde 'Development and Evaluation of Floating Tablets of Salbutamol Sulphate' International Journal of Pharma Research and Development, 2010; Volume-2, 1-7.
20. Sandhiya K. M, Shanmugam. S and Vetrichel van T Design and Development of Ambroxol Hydrochloride Sustained Release Matrix Tablets International Journal of Pharmacy and Pharmaceutical Sciences 2011. Vol 3 Suppl 3.